UY31807A - Encapsulación de agentes biológicamente activos - Google Patents
Encapsulación de agentes biológicamente activosInfo
- Publication number
- UY31807A UY31807A UY0001031807A UY31807A UY31807A UY 31807 A UY31807 A UY 31807A UY 0001031807 A UY0001031807 A UY 0001031807A UY 31807 A UY31807 A UY 31807A UY 31807 A UY31807 A UY 31807A
- Authority
- UY
- Uruguay
- Prior art keywords
- biologically active
- active agents
- encapsulation
- compositions
- vehicles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
La presente invención proporciona procedimientos para encapsular agentes biológicamente activos tales como proteínas en vehículos en forma de partículas tales como nanopartículas. También se proporcionan composiciones que comprenden vehículos en forma de partículas que pueden obtenerse por dichos procedimientos y usos de dichas composiciones en un tratamiento.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5077508P | 2008-05-06 | 2008-05-06 | |
US7417108P | 2008-06-20 | 2008-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31807A true UY31807A (es) | 2009-12-14 |
Family
ID=40944671
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001031809A UY31809A (es) | 2008-05-06 | 2009-05-05 | Encapsulación de agentes biológicamente activos |
UY0001031807A UY31807A (es) | 2008-05-06 | 2009-05-05 | Encapsulación de agentes biológicamente activos |
UY0001031810A UY31810A (es) | 2008-05-06 | 2009-05-05 | Encapsulación de agentes biológicamente activos |
UY0001031808A UY31808A (es) | 2008-05-06 | 2009-05-05 | Encapsulación de agentes biológicamente activos |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001031809A UY31809A (es) | 2008-05-06 | 2009-05-05 | Encapsulación de agentes biológicamente activos |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001031810A UY31810A (es) | 2008-05-06 | 2009-05-05 | Encapsulación de agentes biológicamente activos |
UY0001031808A UY31808A (es) | 2008-05-06 | 2009-05-05 | Encapsulación de agentes biológicamente activos |
Country Status (11)
Country | Link |
---|---|
US (1) | US20110064821A1 (es) |
EP (2) | EP2271323A2 (es) |
JP (1) | JP2011522792A (es) |
KR (3) | KR20110015604A (es) |
AR (4) | AR071634A1 (es) |
CA (1) | CA2721241A1 (es) |
CL (4) | CL2009001076A1 (es) |
PE (4) | PE20091829A1 (es) |
TW (4) | TW201006495A (es) |
UY (4) | UY31809A (es) |
WO (1) | WO2009135853A2 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA201001568A1 (ru) * | 2008-05-06 | 2011-10-31 | Глаксо Груп Лимитед | Инкапсуляция биологически активных агентов |
US9504759B2 (en) | 2011-08-11 | 2016-11-29 | Bar-Ilan University | Surface modified proteinaceous spherical particles and uses thereof |
US10112988B2 (en) | 2012-01-09 | 2018-10-30 | Icb International, Inc. | Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide |
US10112987B2 (en) | 2012-01-09 | 2018-10-30 | Icb International, Inc. | Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide |
AU2015265872B2 (en) * | 2014-05-30 | 2020-04-09 | AbbVie Deutschland GmbH & Co. KG | Nanoencapsulation of antigen-binding molecules |
SG11201609954VA (en) * | 2014-05-30 | 2016-12-29 | Abbvie Deutschland | Highly drug-loaded poly(alkyl 2-cyanoacrylate) nanocapsules |
ES2906726T3 (es) * | 2014-06-12 | 2022-04-20 | Adare Pharmaceuticals Usa Inc | Composiciones de administración de fármaco de liberación prolongada |
AU2015280417B2 (en) | 2014-06-24 | 2020-01-30 | The Trustees Of Princeton University | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
WO2019055539A1 (en) | 2017-09-12 | 2019-03-21 | Prudhomme Robert K | CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME |
US11731099B2 (en) | 2018-07-20 | 2023-08-22 | The Trustees Of Princeton University | Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation |
US20220031630A1 (en) * | 2018-09-13 | 2022-02-03 | The Brigham And Women's Hospital, Inc. | Nanoparticle formulations and methods of their use |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4833666A (en) | 1986-12-24 | 1989-05-23 | U.S. Philips Corporation | Disc-record player suitable for scanning disc of different types |
FR2649321A1 (fr) * | 1989-07-07 | 1991-01-11 | Inst Nat Sante Rech Med | Compositions a base de derives nucleotidiques, leurs procedes de preparation, et leurs utilisations notamment en tant que compositions pharmaceutiques |
FR2659554B1 (fr) * | 1990-03-16 | 1994-09-30 | Oreal | Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant. |
EP0683667A1 (en) * | 1993-02-15 | 1995-11-29 | Shield Research Limited | Polyalkylcyanoacrylate nanocapsules |
HUT74509A (en) * | 1993-09-09 | 1997-01-28 | Schering Ag | Active principles and gas containing microparticles, their use for realising active principles in ultrasonically controlled manner, and process for preparing them |
DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
GB9809839D0 (en) | 1998-05-09 | 1998-07-08 | Glaxo Group Ltd | Antibody |
IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
US7115396B2 (en) | 1998-12-10 | 2006-10-03 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
US20030152636A1 (en) * | 2000-02-23 | 2003-08-14 | Nanopharm Ag | Method of treating cancer |
JP5291279B2 (ja) | 2000-09-08 | 2013-09-18 | ウニヴェルジテート・チューリッヒ | 反復モジュールを含む反復タンパク質の集合体 |
CA2452382A1 (en) * | 2001-07-10 | 2003-01-23 | Corixa Corporation | Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
TWI323265B (en) | 2002-08-06 | 2010-04-11 | Glaxo Group Ltd | Antibodies |
WO2005003156A1 (en) | 2003-07-04 | 2005-01-13 | Affibody Ab | Polypeptides having binding affinity for her2 |
AU2003275958A1 (en) | 2003-08-25 | 2005-03-10 | Pieris Proteolab Ag | Muteins of tear lipocalin |
BRPI0417302A (pt) | 2003-12-05 | 2007-03-06 | Compound Therapeutics Inc | inibidores de receptores de fator de crescimento endotelial vascular do tipo 2 |
DK1796650T3 (da) | 2004-09-14 | 2009-03-09 | Nanodel Technologies Gmbh | Transport- og afgivelsesvehikel indeholdende nanopartikler |
GB0525662D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Immunoglobulins |
EP2177536B1 (en) | 2006-03-30 | 2014-06-04 | Glaxo Group Limited | Antibodies against amyloid-beta peptide |
EP1958957A1 (en) | 2007-02-16 | 2008-08-20 | NascaCell Technologies AG | Polypeptide comprising a knottin protein moiety |
CN101679511A (zh) | 2007-06-06 | 2010-03-24 | 杜门蒂斯有限公司 | 多肽、抗体可变域和拮抗剂 |
GB0724331D0 (en) | 2007-12-13 | 2008-01-23 | Domantis Ltd | Compositions for pulmonary delivery |
-
2009
- 2009-05-05 CA CA2721241A patent/CA2721241A1/en not_active Abandoned
- 2009-05-05 UY UY0001031809A patent/UY31809A/es unknown
- 2009-05-05 PE PE2009000607A patent/PE20091829A1/es not_active Application Discontinuation
- 2009-05-05 TW TW098114867A patent/TW201006495A/zh unknown
- 2009-05-05 PE PE2009000608A patent/PE20091964A1/es not_active Application Discontinuation
- 2009-05-05 CL CL2009001076A patent/CL2009001076A1/es unknown
- 2009-05-05 PE PE2009000609A patent/PE20091965A1/es not_active Application Discontinuation
- 2009-05-05 US US12/991,556 patent/US20110064821A1/en not_active Abandoned
- 2009-05-05 KR KR1020107027425A patent/KR20110015604A/ko not_active Application Discontinuation
- 2009-05-05 AR ARP090101618A patent/AR071634A1/es not_active Application Discontinuation
- 2009-05-05 CL CL2009001080A patent/CL2009001080A1/es unknown
- 2009-05-05 EP EP09742071A patent/EP2271323A2/en not_active Withdrawn
- 2009-05-05 CL CL2009001081A patent/CL2009001081A1/es unknown
- 2009-05-05 PE PE2009000606A patent/PE20091882A1/es not_active Application Discontinuation
- 2009-05-05 KR KR1020107027449A patent/KR20110010760A/ko not_active Application Discontinuation
- 2009-05-05 JP JP2011507897A patent/JP2011522792A/ja active Pending
- 2009-05-05 TW TW098114851A patent/TW201012488A/zh unknown
- 2009-05-05 AR ARP090101619A patent/AR072668A1/es not_active Application Discontinuation
- 2009-05-05 UY UY0001031807A patent/UY31807A/es unknown
- 2009-05-05 UY UY0001031810A patent/UY31810A/es unknown
- 2009-05-05 AR ARP090101617A patent/AR072359A1/es not_active Application Discontinuation
- 2009-05-05 AR ARP090101616A patent/AR071633A1/es not_active Application Discontinuation
- 2009-05-05 TW TW098114865A patent/TW201012490A/zh unknown
- 2009-05-05 UY UY0001031808A patent/UY31808A/es unknown
- 2009-05-05 EP EP11192165A patent/EP2441447A1/en not_active Withdrawn
- 2009-05-05 TW TW098114853A patent/TW201012489A/zh unknown
- 2009-05-05 KR KR1020107027240A patent/KR20110010758A/ko not_active Application Discontinuation
- 2009-05-05 CL CL2009001077A patent/CL2009001077A1/es unknown
- 2009-05-05 WO PCT/EP2009/055436 patent/WO2009135853A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
UY31810A (es) | 2009-12-14 |
PE20091829A1 (es) | 2009-12-12 |
AR071633A1 (es) | 2010-06-30 |
KR20110010758A (ko) | 2011-02-07 |
CL2009001080A1 (es) | 2010-09-24 |
WO2009135853A2 (en) | 2009-11-12 |
EP2271323A2 (en) | 2011-01-12 |
AR072359A1 (es) | 2010-08-25 |
PE20091964A1 (es) | 2010-01-09 |
TW201006495A (en) | 2010-02-16 |
JP2011522792A (ja) | 2011-08-04 |
PE20091965A1 (es) | 2010-01-09 |
CL2009001076A1 (es) | 2010-09-24 |
CA2721241A1 (en) | 2009-11-12 |
AR071634A1 (es) | 2010-06-30 |
KR20110015604A (ko) | 2011-02-16 |
UY31809A (es) | 2009-12-14 |
AR072668A1 (es) | 2010-09-15 |
TW201012488A (en) | 2010-04-01 |
CL2009001081A1 (es) | 2010-09-24 |
KR20110010760A (ko) | 2011-02-07 |
PE20091882A1 (es) | 2009-12-24 |
US20110064821A1 (en) | 2011-03-17 |
WO2009135853A3 (en) | 2011-05-12 |
EP2441447A1 (en) | 2012-04-18 |
TW201012489A (en) | 2010-04-01 |
UY31808A (es) | 2009-12-14 |
TW201012490A (en) | 2010-04-01 |
CL2009001077A1 (es) | 2010-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31810A (es) | Encapsulación de agentes biológicamente activos | |
BR112013027500A2 (pt) | liberação controlada de imunossupressores de nanotransportadores sintéticos | |
IN2014DN06529A (es) | ||
NZ719345A (en) | Lipid nanoparticle compositions and methods for mrna delivery | |
MX354137B (es) | Composiciones topicas de minociclina y metodos de uso de la misma. | |
SG10201408166QA (en) | Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion | |
CA2863681A1 (en) | Topical use of a skin-commensal prebiotic agent and compositions containing the same | |
IN2014MN01879A (es) | ||
AR090465A1 (es) | Formas solidas de un profarmaco de nucleotidos de tiofosforamidato | |
MX2013009175A (es) | Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas. | |
CO6551683A2 (es) | Tratamiento para trastornos gastrointestinales | |
BRPI0912230A2 (pt) | Método para encapsular agentes biologicamente ativos em um carreador particulado, carreador particulado, e, composição farmacêutica | |
IN2014DN08721A (es) | ||
EA201190295A1 (ru) | Композиции для дермальной доставки, содержащие комплексы активного агента с частицами фосфата кальция, и способы их применения | |
CR20140594A (es) | Composiciones farmacéuticas y tratamiento de mastitis | |
TR201818992T4 (tr) | Polimerik Finasterid Nanoparçacık, Bunu İçeren Sulu Bileşim, Alopesi Tedavisine Yönelik Bileşim, Bahsedilen Bileşimi Hazırlamaya Yönelik Metot Ve Bunların Kullanımı | |
BR112013000779A2 (pt) | composições farmacêuticas de combinação, métodos de tratamento de paciente e uso de forma potencializada ativada de anticorpo para receptor at1 de angiotensina ii e forma potencializada ativada de anticorpo para sintase no endotelial | |
PL2753182T3 (pl) | Środki czynne przeciw szczepom Pseudomonas powodującym choroby gnilne w uprawach grzybów, ich zastosowanie i zawierające je kompozycje | |
CR20110550S (es) | Botella | |
NI201100008A (es) | Nuevas posibilidades de lucha contra la giardiasis. | |
IL246448A0 (en) | Preparations and methods for transferring active telomerase to cells in vivo | |
BR112012026542A2 (pt) | abordagem seletiva de tecido | |
WO2009135854A3 (en) | Encapsulation of biologically active agents | |
WO2014031982A3 (en) | Methods and compositions for treating pain | |
IN2015DN04074A (es) |